Case Study: Leading Biotechnology Company achieves global social media compliance for COVID-19 vaccine rollout with Resolver

Leading biotechnology company scales social media compliance globally for COVID‑19 vaccine rollout

The Leading Biotechnology Company faced a surge of online misinformation and compliance risks as it rolled out its COVID-19 vaccine globally, turning a once-manageable social media presence into a high-volume, high-stakes challenge. To protect its communities and maintain regulatory compliance, it needed a formal risk intelligence approach and support for its social channels, including Facebook, Instagram, Twitter, and LinkedIn.

Resolver implemented its Pharma Compliance solution, along with Threat Defense, to monitor, categorize, and escalate harmful content across multiple languages and geographies 24/7/365. Over six months, Resolver reviewed more than 250,000 comments, representing 500% growth in digital chatter, identified 10,741 misinformation items, removed or hid 295 comments, and flagged 640 potential adverse events on Twitter alone, helping the company scale safely and securely.